Detalhe da pesquisa
1.
Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?
Clin Adv Hematol Oncol
; 22(5): 217-226, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38805313
2.
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC.
Future Oncol
; 19(21): 1461-1472, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249038
3.
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.
Oncologist
; 23(10): 1199-1209, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29650684
4.
Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial.
Invest New Drugs
; 35(6): 813-819, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28936567
5.
Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated With Tyrosine Kinase Inhibitors.
Oncology (Williston Park)
; 30(7): 601-12, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27432364
6.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25704439
7.
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
Oncologist
; 20(10): 1175-81, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26330460
8.
Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657818
9.
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases.
RMD Open
; 9(4)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914179
10.
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
Clin Lung Cancer
; 24(7): e242-e246, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451930
11.
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
J Neurosurg
; 136(1): 56-66, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087798
12.
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
Front Oncol
; 12: 945798, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992816
13.
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(7): 620-629, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045016
14.
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688557
15.
Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?
Oncology (Williston Park)
; 24(10): 888-98, 900, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21138169
16.
The time for low-dose computed tomography screening is now: a medical oncologist perspective.
Oncology (Williston Park)
; 28(11): 964-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381211
17.
Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer.
Oncology (Williston Park)
; 28(6): 526, 528, 530, 534, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25134330
18.
A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer.
Cancer Treat Res Commun
; 20: 100150, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102920
19.
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.
Eur J Cancer
; 108: 120-128, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654297
20.
Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.
Am J Clin Oncol
; 41(8): 820-825, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301349